We are live on
!
Find out more
ACM
AIGH Capital Management Portfolio holdings
AUM
$733M
1-Year Est. Return
327.32%
This Fund
S&P 500
This Quarter
Est. Return
+39.08%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
–
AUM
$222M
AUM Growth
-$19.2M
(-8%)
Cap. Flow
-$54.1M
Cap. Flow
% of AUM
-24.33%
Top 10 Holdings %
Top 10 Hldgs %
60.52%
Holding
43
New
2
Increased
13
Reduced
14
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
nLIGHT
LASR
|
+$7.46M |
| 2 |
Domo
DOMO
|
+$5.93M |
| 3 |
Allient
ALNT
|
+$5.56M |
| 4 |
Vishay Precision Group
VPG
|
+$3.94M |
| 5 |
Myomo
MYO
|
+$2.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BK Technologies
BKTI
|
+$10.5M |
| 2 |
Akebia Therapeutics
AKBA
|
+$5.62M |
| 3 |
Intellicheck
IDN
|
+$5.52M |
| 4 |
Zevra Therapeutics
ZVRA
|
+$4.21M |
| 5 |
Delcath Systems
DCTH
|
+$3.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 51.2% |
| 2 | Technology | 34.94% |
| 3 | Industrials | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
KALA BIO
KALA
$14.4M
| $1.43M | 0.64% |
6,000
+2,073
| +53% | +$404K |
|
27
Neuraxis
NRXS
$87.5M
| $968K | 0.44% |
400,000
+380,131
| +1,913% | +$890K |
|
28
Aprea Therapeutics
APRE
$7.42M
| $913K | 0.41% |
539,300
| – | – |
|
|
29
Intellicheck
IDN
$78.6M
| $831K | 0.37% |
154,174
-1,443,364
| -90% | -$5.52M |
|
30
BiomX
PHGE
$1.97M
| $705K | 0.32% |
82,471
| – | – |
|
31
Biofrontera
BFRI
$15.6M
| $693K | 0.31% |
974,525
+242,370
| +33% | +$169K |
|
32
Kiora Pharmaceuticals
KPRX
$10.9M
| $623K | 0.28% |
216,345
-37,210
| -15% | -$113K |
|
33
Franklin Wireless
FKWL
$26.8M
| $584K | 0.26% |
139,702
-245,648
| -64% | -$1.12M |
|
|
SMTK
34
SmartKem
SMTK
$3.51M
| $439K | 0.2% |
438,685
+147,004
| +50% | +$261K |
|
35
IN8bio
INAB
$9.45M
| $313K | 0.14% |
149,895
+101,562
| +210% | +$413K |
|
|
36
Akebia Therapeutics
AKBA
$354M
| – | – |
-2,925,000
| Closed | -$5.62M |
|
37
Digital Turbine
APPS
$1.15B
| – | – |
-430,849
| Closed | -$1.17M |
|
38
Biodesix
BDSX
$236M
| – | – |
-213,630
| Closed | -$2.67M |
|
|
39
BK Technologies
BKTI
$301M
| – | – |
-268,180
| Closed | -$10.5M |
|
|
40
Delcath Systems
DCTH
$454M
| – | – |
-260,719
| Closed | -$3.32M |
|
41
PUT
iShares Russell 2000 ETF
IWM
$83B
| – | – |
-40,000
| Closed | -$7.98M |
|
42
PUT
Invesco QQQ Trust
QQQ
$485B
| – | – |
-70,000
| Closed | -$32.8M |
|
43
TELA Bio
TELA
$40.6M
| – | – |
-1,416,323
| Closed | -$1.73M |
|
Similar funds
GFI
IA
SI
GIC
CT
TWP
GWS
JJBC
AIGH Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, AIGH Capital Management held 43 positions worth $222M, down 8% from $242M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
AIGH Capital Management withdrew a net $54.1M in Q2 2025, closing 8 positions and reducing 14 holdings. Its most notable exit was BK Technologies, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 51% a quarter earlier, followed by Technology and Industrials.
Against the trend, AIGH Capital Management opened a new position in nLIGHT worth $11.8M.
- AIGH Capital Management's largest Q2 2025 buy was nLIGHT: 600,103 shares worth $11.8M.
- AIGH Capital Management added most to Domo in Q2 2025, an estimated $5.93M increase.
- AIGH Capital Management's biggest Q2 2025 reduction was Intellicheck, cutting an estimated $5.52M.
- AIGH Capital Management fully exited BK Technologies in Q2 2025, selling an estimated $10.5M.
- AIGH Capital Management's ten largest holdings make up 61% of its $222M portfolio in Q2 2025.
- AIGH Capital Management opened 2 new positions and closed 8 in Q2 2025.
- AIGH Capital Management's portfolio value fell 8% quarter-over-quarter to $222M.
Based on AIGH Capital Management's 13F filing for Q2 2025, filed 29 Jul 2025.